The Global Alzheimers Platform Foundation Inc is dedicated to combating Alzheimer's disease and other forms of dementia by uniting academic researchers, pharmaceutical companies, nonprofit organizations, foundations, and governments worldwide. With an operating budget of $10.6 million and total revenue of $6.5 million for the filing year 2024, the organization aims to reduce the time, cost, and risk associated with Alzheimer's clinical trials, thereby accelerating the development of innovative treatments. The foundation does not rely on a single funder for 50% or more of its revenue, ensuring diverse support for its mission. For more information, visit www.globalalzplatform.org.